Recent progress in understanding pediatric pulmonary hypertension
- 1 June 2011
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Pediatrics
- Vol. 23 (3), 298-304
- https://doi.org/10.1097/mop.0b013e3283464a52
Abstract
Purpose of review Pulmonary artery hypertension (PAH) in children contributes significantly to morbidity and mortality in diverse pediatric cardiac, lung, hematologic and other diseases. Advances in pulmonary vascular biology over the past few decades have significantly expanded therapeutic strategies; however, many unique issues persist regarding our understanding of pediatric PAH. Recent findings Recent studies of pediatric PAH include those that highlight gaps in our understanding of pediatric diseases associated with PAH from those of adult onset, emphasizing the strong need for specific studies regarding unique aspects of the pathogenesis and treatment of children with PAH. Registries have begun to provide new data showing differences in physiology, course, and genetics between adult and pediatric forms of PAH. Unfortunately, therapeutic strategies in pediatric pulmonary hypertension are often limited to small observational studies in children and are dependent on results from larger adult studies. In addition, clinical endpoints for studies and care remain poorly defined in infants and children. Summary Despite many advances, long-term outcomes for children with PAH remain guarded and substantial challenges persist, especially with regard to understanding mechanisms and approach to severe PAH. Future studies are needed to develop novel biomarkers, clinical endpoints and interventions for young children with diverse causes of PAH.Keywords
This publication has 58 references indexed in Scilit:
- Intravenous sildenafil for postoperative pulmonary hypertension in children with congenital heart diseaseIntensive Care Medicine, 2010
- Treprostinil increases the number and angiogenic potential of endothelial progenitor cells in children with pulmonary hypertensionAngiogenesis, 2010
- Long-Term Outcomes in Children With Pulmonary Arterial Hypertension Treated With Bosentan in Real-World Clinical SettingsThe American Journal of Cardiology, 2010
- Medical Therapy for Pediatric Pulmonary Arterial HypertensionThe Journal of Pediatrics, 2010
- Non-congenital heart disease associated pediatric pulmonary arterial hypertensionProgress in Pediatric Cardiology, 2009
- Prospective Echocardiography Assessment of Pulmonary Hypertension and Its Potential Etiologies in Children With Sickle Cell DiseaseThe American Journal of Cardiology, 2009
- Effects of Long-Term Sildenafil Treatment for Pulmonary Hypertension in Infants with Chronic Lung DiseaseThe Journal of Pediatrics, 2009
- Short- and Long-Term Effects of Inhaled Iloprost Therapy in Children With Pulmonary Arterial HypertensionJournal of the American College of Cardiology, 2008
- Transition of Stable Pediatric Patients With Pulmonary Arterial Hypertension from Intravenous Epoprostenol to Intravenous TreprostinilThe American Journal of Cardiology, 2007
- Clinical classification of pulmonary hypertensionJournal of the American College of Cardiology, 2004